Key result
scFv antibodies targeting NS1 protein variability show potential for Orthoflavivirus differential diagnosis.
May advance Orthoflavivirus diagnostics; leaves open clinical validation before any practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Souza et al. (2026) studied this question. scFv antibodies targeting the antigenic variability of the NS1 protein are proposed for the differential diagnosis of Orthoflavivirus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: